Zai Lab Limited (ZLAB)
NASDAQ: ZLAB
· Real-Time Price · USD
35.81
0.08 (0.22%)
At close: Aug 18, 2025, 1:40 PM
0.22% (1D)
| Bid | 35.81 |
| Market Cap | 3.94B |
| Revenue (ttm) | 427.8M |
| Net Income (ttm) | -212.52M |
| EPS (ttm) | -2 |
| PE Ratio (ttm) | -17.9 |
| Forward PE | 53.79 |
| Analyst | Buy |
| Ask | 35.87 |
| Volume | 148,270 |
| Avg. Volume (20D) | 839,825 |
| Open | 36.27 |
| Previous Close | 35.73 |
| Day's Range | 35.81 - 36.75 |
| 52-Week Range | 16.56 - 44.34 |
| Beta | 1.03 |
About ZLAB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZLAB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZLAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Zai Lab Limited is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-11.98%
Zai Lab shares are trading lower after the company...
Unlock content with
Pro Subscription
4 months ago
+6.69%
Zai Lab shares are trading higher on possible continued strength after the company announced yesterday that it will present new data for oncology candidates at the upcoming annual 2025 American Association For Cancer Research. Additionally, Cantor Fitzgerald reiterated an Overweight rating on the stock.
